Novel GLP-1 Agonist Promotes Safe and Effective Weight Loss

medscape.com/viewarticle/novel-glp-1-agonist-promotes-safe-and-effective-weight-loss-2025a1000gll

Ecnoglutide, a novel glucagon-like peptide-1 (GLP-1) receptor agonist, was significantly more effective than placebo for inducing weight loss in adults with overweight or obesity, based on data from more than 600 individuals, results of the SLIMMER trial showed.
In addition, ecnoglutide…

This story appeared on medscape.com, 2025-06-23 04:52:49.683000.
The Entire Business World on a Single Page. Free to Use →